Nicholas Hoffman & Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,154
| Closed | -$650K | – | 293 |
|
|
2024
Q1 | $650K | Buy |
8,154
+317
| +4% | +$24.2K | 0.03% | 160 |
|
|
2023
Q4 | $619K | Sell |
7,837
-942
| -11% | -$67K | 0.04% | 159 |
|
|
2023
Q3 | $613K | Buy |
8,779
+1,282
| +17% | +$90.8K | 0.05% | 155 |
|
|
2023
Q2 | $518K | Sell |
7,497
-92
| -1% | -$6.55K | 0.02% | 172 |
|
|
2023
Q1 | $564K | Buy |
7,589
+511
| +7% | +$42.9K | 0.05% | 160 |
|
|
2022
Q4 | $660K | Buy |
7,078
+305
| +5% | +$29.4K | 0.07% | 142 |
|
|
2022
Q3 | $646K | Buy |
6,773
+5
| +0.1% | +$495 | 0.03% | 135 |
|
|
2022
Q2 | $627K | Buy |
6,768
+105
| +2% | +$10.2K | 0.03% | 139 |
|
|
2022
Q1 | $674K | Buy |
6,663
+339
| +5% | +$35.6K | 0.03% | 142 |
|
|
2021
Q4 | $652K | Buy |
6,324
+4
| +0.1% | +$370 | 0.02% | 146 |
|
|
2021
Q3 | $536K | Buy |
6,320
+5
| +0.1% | +$419 | 0.09% | 151 |
|
|
2021
Q2 | $527K | Buy |
6,315
+133
| +2% | +$10.9K | 0.1% | 153 |
|
|
2021
Q1 | $465K | Sell |
6,182
-70
| -1% | -$5.1K | 0.09% | 156 |
|
|
2020
Q4 | $427K | Buy |
6,252
+87
| +1% | +$5.66K | 0.1% | 146 |
|
|
2020
Q3 | $360K | Buy |
6,165
+103
| +2% | +$6.41K | 0.1% | 143 |
|
|
2020
Q2 | $394K | Sell |
6,062
-92
| -1% | -$5.79K | 0.11% | 136 |
|
|
2020
Q1 | $365K | Buy |
6,154
+1,923
| +45% | +$128K | 0.12% | 134 |
|
|
2019
Q4 | $314K | Sell |
4,231
-2,524
| -37% | -$177K | 0.09% | 154 |
|
|
2019
Q3 | $426K | Buy |
6,755
+2,024
| +43% | +$120K | 0.13% | 133 |
|
|
2019
Q2 | $258K | Buy |
4,731
+368
| +8% | +$19.8K | 0.08% | 163 |
|
|
2019
Q1 | $235K | Sell |
4,363
-70
| -2% | -$4.32K | 0.08% | 158 |
|
|
2018
Q4 | $290K | Sell |
4,433
-504
| -10% | -$37.6K | 0.1% | 139 |
|
|
2018
Q3 | $389K | Buy |
+4,937
| New | +$353K | 0.13% | 129 |
|
|
2018
Q2 | – | Sell |
-7,887
| Closed | -$491K | – | 174 |
|
|
2018
Q1 | $491K | Sell |
7,887
-4,028
| -34% | -$289K | 0.19% | 107 |
|
|
2017
Q4 | $864K | Sell |
11,915
-2,442
| -17% | -$178K | 0.34% | 76 |
|
|
2017
Q3 | $1.17M | Sell |
14,357
-15
| -0.1% | -$1.19K | 0.49% | 56 |
|
|
2017
Q2 | $1.16M | Buy |
14,372
+295
| +2% | +$23.3K | 0.53% | 54 |
|
|
2017
Q1 | $1.1M | Buy |
14,077
+4,360
| +45% | +$348K | 0.52% | 55 |
|
|
2016
Q4 | $781K | Buy |
9,717
+6,250
| +180% | +$506K | 0.39% | 65 |
|
|
2016
Q3 | $309K | Buy |
3,467
+250
| +8% | +$23.6K | 0.17% | 111 |
|
|
2016
Q2 | $308K | Buy |
+3,217
| New | +$321K | 0.18% | 104 |
|
Other funds holding CVS
Nicholas Hoffman & Company's CVS Position: Q2 2024 in Review
Nicholas Hoffman & Company sold out of CVS Health (CVS) in Q2 2024, closing a stake of 8,154 shares — an estimated $650K sold.
Nicholas Hoffman & Company first reported a position in CVS in Q2 2016 and held it in 31 quarters. The position peaked at $1.17M in Q3 2017. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Nicholas Hoffman & Company reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Nicholas Hoffman & Company sold 8,154 CVS Health shares in Q2 2024, an estimated $650K.
- Nicholas Hoffman & Company first reported a position in CVS Health in Q2 2016 and held it in 31 quarters.
- Nicholas Hoffman & Company's CVS Health position peaked at $1.17M in Q3 2017.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Nicholas Hoffman & Company's 13F filing for Q2 2024, filed 2 Aug 2024.